Spots Global Cancer Trial Database for Facing Obstacles to RDI (Relative Dose Intensity) Through Telephone Intervention Strategy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Facing Obstacles to RDI (Relative Dose Intensity) Through Telephone Intervention Strategy
Official Title: Facing Obstacles to RDI(Relative Dose Intensity)Through Telephone Intervention Strategy
Study ID: NCT01393366
Conditions
Study Description
Brief Summary: The investigators plan to conduct a nurse-based telephone intervention study to minimize toxicity and increase compliance to a combination of Fludarabine-Cyclophosphamide-Rituximab (FCR) given frontline to Chronic Lymphocytic Leukemia patients.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centre Hospitalier de la côte basque, Bayonne, , France
CH Saint Jean, Perpignan, , France
CHU Purpan, Toulouse, , France
Contact Details
Name: Loïc YSEBAERT, MD
Affiliation: University Hospital Of Toulouse
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
